Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Opportunity to comment on the design of the upcoming Reimbursement/HTA decisions database from MTRC

02 Jun 2023

MTRC is developing a novel digital product - Reimbursement and HTA Market Intelligence Database, which will allow access to the historical reimbursement/HTA decisions for individual technology groups (e.g. cardiovascular, robotic, IVD etc.), for individual countries, filtering decisions by type of decision (e.g. procedure coding, payment mechanisms, innovation funding etc.).

There will be a small overlap between the upcoming database product and the existing Reimbursement and HTA Alerts newsletter; however, the database will offer much broader functionality and several additional benefits.

We invite our existing and prospective clients to comment on the design of the upcoming solution, so that we can improve the design/functionality to meet the ultimate needs of the users. This gives the ability to potential future users of the product to have the product they really need. 

If you are interested in having a 30-min call with our team about the upcoming digital solution, please, send a request to The consultation period runs until 30th of June 2023.